Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-06-07

Clinical Trial Update: Optimal Protein Supplementation for Critically Ill Patients [NA]

View source ↗

Summary

The clinical trial NCT01934595 investigating optimal protein supplementation for critically ill patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oklahoma | Conditions: Critical Illness | NA | Status: WITHDRAWN